{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:19:58Z","timestamp":1790997598053,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370683"],"award-info":[{"award-number":["82370683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700642"],"award-info":[{"award-number":["81700642"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bj.2024.100730","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T01:48:28Z","timestamp":1713577708000},"page":"100730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Olesoxime protects against cisplatin-induced acute kidney injury by attenuating mitochondrial dysfunction"],"prefix":"10.1016","volume":"48","author":[{"given":"Peipei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-5716","authenticated-orcid":false,"given":"Yunwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12882-017-0622-6","article-title":"Incidence and diagnosis of Acute kidney injury in hospitalized adult patients: a retrospective observational study in a tertiary teaching Hospital in Southeast China","volume":"18","author":"Cheng","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.bj.2024.100730_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-3-319-55330-6_27","article-title":"Mitochondria damage and kidney disease","volume":"982","author":"Duann","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.bj.2024.100730_bib3","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/ijms20123011","article-title":"Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury","volume":"20","author":"Holditch","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152007779314044","article-title":"Biochemical mechanisms of cisplatin cytotoxicity","volume":"7","author":"Cepeda","year":"2007","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.bj.2024.100730_bib5","article-title":"Cellular responses to Cisplatin-induced DNA damage","volume":"2010:201367","author":"Basu","year":"2010","journal-title":"J Nucleic Acids"},{"issue":"11","key":"10.1016\/j.bj.2024.100730_bib6","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1681\/ASN.2013121351","article-title":"Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury","volume":"26","author":"Bajwa","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol Rev"},{"issue":"17","key":"10.1016\/j.bj.2024.100730_bib9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1089\/ars.2019.7728","article-title":"S-sulfhydration of SIRT3 by hydrogen sulfide attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury","volume":"31","author":"Yuan","year":"2019","journal-title":"Antioxidants Redox Signal"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ki.2012.441","article-title":"Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology","volume":"83","author":"Zhan","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.bj.2024.100730_bib11","article-title":"Mitochondria-targeted therapies for acute kidney injury","volume":"16","author":"T\u00e1bara","year":"2014","journal-title":"Expet Rev Mol Med"},{"issue":"7","key":"10.1016\/j.bj.2024.100730_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ndt\/gfv317","article-title":"Mitochondria: a therapeutic target in acute kidney injury","volume":"31","author":"Ishimoto","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","article-title":"Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound","volume":"3","author":"Bordet","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.bj.2024.100730_bib14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cpt.2247","article-title":"Prognostic factors and treatment-effect modifiers in spinal muscular atrophy","volume":"110","author":"Baranello","year":"2021","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"18","key":"10.1016\/j.bj.2024.100730_bib15","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1007\/s00018-019-03386-w","article-title":"Molecular mechanism of olesoxime-mediated neuroprotection through targeting \u03b1-synuclein interaction with mitochondrial VDAC","volume":"77","author":"Rovini","year":"2020","journal-title":"Cell Mol Life Sci\u202f: CMLS"},{"issue":"9","key":"10.1016\/j.bj.2024.100730_bib16","article-title":"Olesoxime, a cholesterol-like neuroprotectant restrains synaptic vesicle exocytosis in the mice motor nerve terminals: possible role of VDACs","volume":"1865","author":"Zakyrjanova","year":"2020","journal-title":"Biochim et Biophysica Acta Mol Cell Biol Lipids"},{"issue":"8","key":"10.1016\/j.bj.2024.100730_bib17","first-page":"568","article-title":"Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis","volume":"13","author":"Martin","year":"2010","journal-title":"Idrugs"},{"key":"10.1016\/j.bj.2024.100730_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fphys.2017.00324","article-title":"Olesoxime inhibits cardioplegia-induced ischemia\/reperfusion injury. A study in langendorff-perfused rabbit hearts","volume":"8","author":"Salameh","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1523\/JNEUROSCI.2225-10.2011","article-title":"The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation","volume":"31","author":"Martin","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.bj.2024.100730_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jocn.2015.12.037","article-title":"Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial","volume":"32","author":"Yates","year":"2016","journal-title":"J Clin Neurosci\u202f: Off J Neurosurg Soc Aust"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clinthera.2013.11.006","article-title":"Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials","volume":"36","author":"Zanetta","year":"2014","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.bj.2024.100730_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113286","article-title":"Olesoxime improves cerebral mitochondrial dysfunction and enhances A\u03b2 levels in preclinical models of Alzheimer\u2019s disease","volume":"329","author":"Eckert","year":"2020","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bph.12939","article-title":"Protective role of olesoxime against wild-type \u03b1-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells","volume":"172","author":"Gouarn\u00e9","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24070","article-title":"NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage","volume":"75","author":"Ma","year":"2014","journal-title":"Ann Neurol"},{"issue":"Pt 12","key":"10.1016\/j.bj.2024.100730_bib25","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain\u202f: a journal of neurology"},{"key":"10.1016\/j.bj.2024.100730_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108674","article-title":"Cytoprotective effects of olesoxime on isolated human pancreatic islets in order to attenuate apoptotic pathway","volume":"112","author":"Kaviani","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy","volume":"326","author":"Bordet","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.bj.2024.100730_bib28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fphys.2017.00324","article-title":"Olesoxime inhibits cardioplegia-induced ischemia\/reperfusion injury. A study in langendorff-perfused rabbit hearts","volume":"8","author":"Salameh","year":"2017","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.bj.2024.100730_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1681\/ASN.2007040419","article-title":"HIF activation protects from acute kidney injury","volume":"19","author":"Weidemann","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.bj.2024.100730_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/CS20171625","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury","volume":"132","author":"Yang","year":"2018","journal-title":"Clinical science"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/meth.2001.1266","article-title":"Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies","volume":"25","author":"Rajeevan","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.kint.2020.10.025","article-title":"Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy","volume":"99","author":"Gong","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.kint.2016.10.011","article-title":"Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury","volume":"91","author":"Oh","year":"2017","journal-title":"Kidney Int"},{"issue":"15","key":"10.1016\/j.bj.2024.100730_bib34","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2017.7432","article-title":"Numb depletion promotes drp1-mediated mitochondrial fission and exacerbates mitochondrial fragmentation and dysfunction in acute kidney injury","volume":"30","author":"Liu","year":"2019","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2760(80)90209-X","article-title":"Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids","volume":"620","author":"Benedetti","year":"1980","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.bj.2024.100730_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","article-title":"Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria","volume":"4","author":"Zhong","year":"2015","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1096\/fj.201801417R","article-title":"Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis","volume":"33","author":"Kalpage","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.bj.2024.100730_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphys.2020.00433","article-title":"Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: potential application of natural compounds","volume":"11","author":"Chen","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.bj.2024.100730_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bj.2024.100730_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.bj.2024.100730_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ki.2013.559","article-title":"Rictor\/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury","volume":"86","author":"Li","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.bj.2024.100730_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120071","article-title":"Punicalagin prevents cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammatory response, and apoptosis in rats","volume":"286","author":"Aladaileh","year":"2021","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.bj.2024.100730_bib43","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2174\/1389201022666210810141139","article-title":"Amelioration of cisplatin-induced renal inflammation by recombinant human golimumab in mice","volume":"23","author":"Pavitrakar","year":"2022","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22990","article-title":"Protective effects of recombinant human golimumab and pentoxifylline in nephrotoxicity induced by cisplatin","volume":"36","author":"Pavitrakar","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.bj.2024.100730_bib45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.freeradbiomed.2020.01.182","article-title":"Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2","volume":"152","author":"Yang","year":"2020","journal-title":"Free radical biology & medicine"},{"issue":"2","key":"10.1016\/j.bj.2024.100730_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI77632","article-title":"Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury","volume":"125","author":"Morigi","year":"2015","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib47","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"306","author":"Che","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"20","key":"10.1016\/j.bj.2024.100730_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddh267","article-title":"Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells","volume":"13","author":"Kolesnikova","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"18","key":"10.1016\/j.bj.2024.100730_bib49","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1093\/nar\/gkr546","article-title":"Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria","volume":"39","author":"Karicheva","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.bj.2024.100730_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1440-1797.2012.01572.x","article-title":"Oxidative stress, anti-oxidant therapies and chronic kidney disease","volume":"17","author":"Small","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.bj.2024.100730_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2014.05.012","article-title":"Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons","volume":"69","author":"Richter","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.bj.2024.100730_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.110.167486","article-title":"TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition","volume":"333","author":"Schaller","year":"2010","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.bj.2024.100730_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2950503","article-title":"Mitochondria-targeted antioxidants: future perspectives in kidney ischemia reperfusion injury","volume":"2016","author":"Kezic","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bj.2024.100730_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/164_2016_6","article-title":"The emerging role of mitochondrial targeting in kidney disease","volume":"240","author":"Eirin","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"10.1016\/j.bj.2024.100730_bib55","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/tox.22808","article-title":"p53-Dependent pathway and the opening of mPTP mediate the apoptosis of co-cultured Sertoli-germ cells induced by microcystin-LR","volume":"34","author":"Wu","year":"2019","journal-title":"Environ Toxicol"},{"issue":"8","key":"10.1016\/j.bj.2024.100730_bib56","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbalip.2018.04.021","article-title":"Palmitate lipotoxicity in enteric glial cells: lipid remodeling and mitochondrial ROS are responsible for cyt c release outside mitochondria","volume":"1863","author":"Macchioni","year":"2018","journal-title":"Biochimica et biophysica acta Molecular and cell biology of lipids"},{"key":"10.1016\/j.bj.2024.100730_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mito.2022.01.006","article-title":"Targeting the mitochondrial permeability transition pore for drug discovery: challenges and opportunities","volume":"63","author":"Boyenle","year":"2022","journal-title":"Mitochondrion"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:51:25Z","timestamp":1778867485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417024000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2319417024000337"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100730","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olesoxime protects against cisplatin-induced acute kidney injury by attenuating mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100730"}}